Analysts Offer Insights on Financial Companies: CME Group (CME) and Synchrony Financial (SYF)
TipRanks (Thu, 25-Apr 8:06 AM ET)
TipRanks (Thu, 25-Apr 7:11 AM ET)
KBW Reaffirms Their Hold Rating on CME Group (CME)
TipRanks (Thu, 25-Apr 1:26 AM ET)
CME Group Q1 earnings beat consensus, as clearing and transaction fees rise
Seeking Alpha News (Wed, 24-Apr 8:22 AM ET)
CME Non-GAAP EPS of $2.50 beats by $0.05, revenue of $1.5B beats by $20M
Seeking Alpha News (Wed, 24-Apr 7:02 AM ET)
CME Group Inc. Reports First-Quarter 2024 Financial Results
PRNewswire (Wed, 24-Apr 7:00 AM ET)
Seeking Alpha News (Tue, 23-Apr 12:19 PM ET)
Notable earnings before Wednesday's open
Seeking Alpha News (Tue, 23-Apr 10:25 AM ET)
CME Group U.S. Credit Futures to Begin Trading on June 17
PRNewswire (Tue, 23-Apr 9:00 AM ET)
Earnings week ahead: Tesla, Meta Platforms, Google, Microsoft, Intel, Exxon Mobil, and more
Seeking Alpha News (Sun, 21-Apr 8:00 AM ET)
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018, it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Cme Group - Class A trades on the NASDAQ stock market under the symbol CME.
As of April 25, 2024, CME stock price climbed to $215.64 with 164,563 million shares trading.
CME has a beta of 0.31, meaning it tends to be less sensitive to market movements. CME has a correlation of 0.05 to the broad based SPY ETF.
CME has a market cap of $77.64 billion. This is considered a Large Cap stock.
Last quarter Cme Group - Class A reported $1 billion in Revenue and $2.50 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.05.
In the last 3 years, CME stock traded as high as $256.94 and as low as $166.55.
The top ETF exchange traded funds that CME belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
CME stock has underperformed the market in the last year with a return of +20.4%, while SPY returned +22.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CME shares. However, CME has outperformed the market in the last 3 month and 2 week periods, returning +6.1% and +1.7%, while SPY returned +3.0% and -3.1%, respectively. This indicates CME has been having a stronger performance recently.
CME support price is $210.13 and resistance is $215.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CME stock will trade within this expected range on the day.